Navigation Links
Purdue's gold nanorods brighten future for medical imaging

Researchers at Purdue University have taken a step toward developing a new type of ultra-sensitive medical imaging technique that works by shining a laser through the skin to detect tiny gold nanorods injected into the bloodstream.

In tests with mice, the nanorods yielded images nearly 60 times brighter than conventional fluorescent dyes, including rhodamine, commonly used for a wide range of biological imaging to study the inner workings of cells and molecules.

Findings are detailed in a research paper that appeared online last week in Proceedings of the National Academy of Sciences. The paper was written by researchers in Purdue's Weldon School of Biomedical Engineering and the Department of Chemistry.

The nanorods might be used to develop an advanced medical imaging tool for the early detection of cancer, said Ji-Xin Cheng (pronounced Gee-Shin), an assistant professor of biomedical engineering.The gold rods are about 20 nanometers wide and 60 nanometers long, or roughly 200 times smaller than a red blood cell.

Gold nanorods represent a possible way to overcome barriers in developing advanced medical imaging techniques that use light to analyze blood vessels and underlying tissues.

"One obstacle is that light in the visible spectrum does not pass through tissue very well," said Alexander Wei, an associate professor of chemistry who worked with Cheng and other Purdue researchers, including Philip S. Low, a professor of chemistry.

Imaging methods might be developed using laser pulses in longer wavelengths of light, beyond the visible range in a region of the spectrum called near infrared.

"There is a window of light in the near infrared, wavelengths from about 800 to 1,300 nanometers, which could be harnessed for new imaging technologies," Wei said.

Tiny gold rods with a certain "aspect ratio" of length to width shine brightly when illuminated by light in this spectral region. The gold nanorods are ideal for a type of imaging called "two-photon fluorescence," which provides higher contrast and brighter images than conventional fluorescent imaging methods.

Photons are the individual particles that make up light. In two-photon fluorescence, two photons hit the nanorod at the same time.

Because of the two-photon effect, the method might enable scientists to develop advanced "non-linear optical techniques" that provide better contrast than conventional technologies. Cheng is applying the two-photon fluorescence and other non-linear optical effects to develop imaging methods that provide improved contrast over conventional technologies.

The researchers injected the nanorods into mice and then took images of the tiny structures as the nanorods flowed through blood vessels in the animals' ears. Individual nanorods proved to be 58 times brighter than the two-photon fluorescence from a single rhodamine molecule. Within a half hour after being injected, the nanorods could no longer be observed in the animals' blood, presumably because the rods had been filtered out of the blood by the kidneys.

"To be able to detect cells at an early stage of disease such as cancer, it is important to have a reliable technique that has sensitivity at the single-particle level," Wei said. "The gold nanorods demonstrate that Cheng's nonlinear imaging methods are capable of this level of detection."

The research has been funded by the National Institutes of Health and is affiliated with the Birck Nanotechnology Center and the Bindley Bioscience Center, both in Purdue's Discovery Park, the university's hub for interdisciplinary research.

The research paper was written by Haifeng Wang, a postdoctoral research associate in biomedical engineering; Terry B. Huff, a graduate teaching assistant in chemistry; Daniel A. Zweifel, a graduate student in chemistry; Wei He, a graduate research assistant in chemistry; Low; Wei; and Cheng.


'"/>

Source:Purdue University


Related biology news :

1. HIV vaccine trial breaks ground for future research
2. Prozac for future Plants on Mars
3. Plants reveal a secret and bring researchers nearer a cleaner future
4. Report focuses on challenges to unlocking future promise of vaccines
5. Researchers make long DNA wires for future medical and electronic devices
6. New U. of Colorado at Boulder flu chip may help combat future epidemics, pandemics
7. Understanding the oceans microbes is key to the Earths future
8. Tastier tomatoes in the future?
9. Stable polymer nanotubes may have a biotech future
10. Food-crop yields in future greenhouse-gas conditions lower than expected
11. Brighter future for giant panda?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... ... January 12, 2017 , ... After her brain cancer ... gave her only a few months to live. Now a paper publishing January ... Rosendahl’s disease and increased both the quantity and quality of her life: Adding ...
(Date:1/12/2017)... and Pune, India , January 12, 2017 ... Market by Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," ... 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% during the ... ... Allied Market Research Logo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial ... of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The ... percent of these heavily pretreated patients saw clinical benefit from the drug, with ...
(Date:1/11/2017)... ... January 11, 2017 , ... Photonics industry and STEM ... are commending the U.S. Congress and President Obama for their recognition of the ... the American Innovation and Competitiveness Act (AICA). , The language of the act ...
Breaking Biology Technology: